Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 17 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Game On: Brera Holdings PLC’s (NASDAQ: BREA) MCO Strategy Draws Analyst Support
Brera Holdings (NASDAQ: BREA) is an Ireland-based international holding company focused on expanding its global portfolio…
-
QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug…
-
QualityStocksNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) CEO Featured on IBN’s Bell2Bell Podcast
Strawberry Fields REIT (NYSE AMERICAN: STRW), a self-administered real estate investment trust focused on skilled…